Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model
Gayathri Kollessery, Tara M. Nordgren, Amit K. Mittal, Shantaram S. Joshi, Sam D. Sanderson
Dive into the research topics of 'Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model'. Together they form a unique fingerprint.